PerkinElmer Announces Financial Results for the Third Quarter of 2020

PerkinElmer Announces Financial Results for the Third Quarter of 2020

October 28, 2020 at 4:05 PM EDT
  • Revenue of $964.0 million; 36% reported growth; 34% organic growth
  • GAAP EPS from continuing operations of $1.57; Adjusted EPS of $2.09


WALTHAM, Mass.
--(BUSINESS WIRE)--Oct. 28, 2020-- PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020.

The Company reported GAAP earnings per share from continuing operations of $1.57, as compared to GAAP earnings per share from continuing operations of $0.53 in the third quarter of 2019. GAAP revenue for the quarter was $964.0 million, as compared to $706.9 million in the third quarter of 2019. GAAP operating income from continuing operations for the quarter was $248.0 million, as compared to $78.7 million for the same period a year ago. GAAP operating profit margin was 25.7% as a percentage of revenue, as compared to 11.1% in the third quarter of 2019.

Adjusted earnings per share from continuing operations for the quarter was $2.09, as compared to $1.06 in the third quarter of 2019. Adjusted revenue for the quarter was $964.2 million, as compared to $707.1 million in the third quarter of 2019. Adjusted operating income from continuing operations for the quarter was $304.3 million, as compared to $152.5 million for the same period a year ago. Adjusted operating profit margin was 31.6% as a percentage of adjusted revenue, as compared to 21.6% in the third quarter of 2019.

Adjustments for the Company's non-GAAP financial measures have been noted in the attached reconciliations.

“I remain humbled by and immensely proud of how everyone within PerkinElmer has rallied together to tackle this year’s challenges,” said Prahlad Singh, president and chief executive officer of PerkinElmer. “As we look to 2021 and beyond, the environment will undoubtedly be different from the future we imagined a year ago. However, I could not be more confident that we as an organization are headed in the right direction and better positioned to tackle the challenges of tomorrow.”

Financial Overview by Reporting Segment for the Third Quarter

Discovery & Analytical Solutions

  • Third quarter 2020 revenue was $423.6 million, as compared to $426.9 million for the third quarter of 2019. Reported revenue decreased 1% and organic revenue decreased 3% as compared to the third quarter of 2019.
  • Third quarter 2020 operating income from continuing operations was $42.7 million, as compared to $52.3 million for the comparable prior period.
  • Third quarter 2020 adjusted operating income was $62.5 million, as compared to $86.2 million for the third quarter of 2019.
 

Diagnostics

  • Third quarter 2020 revenue was $540.4 million, as compared to $280.0 million for the third quarter of 2019. Reported revenue increased 93% and organic revenue increased 92% as compared to the third quarter of 2019.
  • Third quarter 2020 operating income from continuing operations was $223.8 million, as compared to $47.4 million for the comparable prior period.
  • Third quarter 2020 adjusted operating income was $260.3 million, as compared to $79.7 million for the third quarter of 2019.

Fourth Quarter 2020 Guidance

For the fourth quarter of 2020, the Company forecasts GAAP revenue in the range of $1.12 billion to $1.23 billion, GAAP earnings per share from continuing operations of $2.27 to $2.67 and, on a non-GAAP basis, which is expected to include the adjustments noted in the attached reconciliation, adjusted earnings per share of $2.60 to $3.00.

Conference Call Information

The Company will discuss its third quarter 2020 results and its outlook for business trends in a conference call on October 28, 2020 at 5:00 p.m. Eastern Time. To access the call, please dial (720) 405-2250 prior to the scheduled conference call time and provide the access code 6884834.

A live audio webcast of the call will be available on the Investors section of the Company’s Web site, www.perkinelmer.com. Please go to the site at least 15 minutes prior to the call in order to register, download, and install any necessary software. An archived version of the webcast will be posted on the Company’s Web site for a two-week period beginning approximately two hours after the call.

Use of Non-GAAP Financial Measures

In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings announcement also contains non-GAAP financial measures. The reasons that we use these measures, a reconciliation of these measures to the most directly comparable GAAP measures, and other information relating to these measures are included below following our GAAP financial statements.

Factors Affecting Future Performance

This press release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to estimates and projections of future earnings per share, cash flow and revenue growth and other financial results, developments relating to our customers and end-markets, and plans concerning business development opportunities, acquisitions and divestitures. Words such as "believes," "intends," "anticipates," "plans," "expects," "projects," "forecasts," "will" and similar expressions, and references to guidance, are intended to identify forward-looking statements. Such statements are based on management's current assumptions and expectations and no assurances can be given that our assumptions or expectations will prove to be correct. A number of important risk factors could cause actual results to differ materially from the results described, implied or projected in any forward-looking statements. These factors include, without limitation: (1) markets into which we sell our products declining or not growing as anticipated; (2) the effect of the COVID-19 pandemic on our sales and operations; (3) fluctuations in the global economic and political environments; (4) our failure to introduce new products in a timely manner; (5) our ability to execute acquisitions and license technologies, or to successfully integrate acquired businesses and licensed technologies into our existing business or to make them profitable, or successfully divest businesses; (6) our failure to adequately protect our intellectual property; (7) the loss of any of our licenses or licensed rights; (8) our ability to compete effectively; (9) fluctuation in our quarterly operating results and our ability to adjust our operations to address unexpected changes; (10) significant disruption in third-party package delivery and import/export services or significant increases in prices for those services; (11) disruptions in the supply of raw materials and supplies; (12) the manufacture and sale of products exposing us to product liability claims; (13) our failure to maintain compliance with applicable government regulations; (14) regulatory changes; (15) our failure to comply with healthcare industry regulations; (16) economic, political and other risks associated with foreign operations; (17) our ability to retain key personnel; (18) significant disruption in our information technology systems, or cybercrime; (19) our ability to obtain future financing; (20) restrictions in our credit agreements; (21) discontinuation or replacement of LIBOR; (22) the United Kingdom’s withdrawal from the European Union; (23) our ability to realize the full value of our intangible assets; (24) significant fluctuations in our stock price; (25) reduction or elimination of dividends on our common stock; and (26) other factors which we describe under the caption "Risk Factors" in our most recent quarterly report on Form 10-Q and in our other filings with the Securities and Exchange Commission. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.

About PerkinElmer

PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.9 billion in 2019, has about 13,000 employees serving customers in more than 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

 
     
  PerkinElmer, Inc. and Subsidiaries  
  CONDENSED CONSOLIDATED INCOME STATEMENTS  
                     
                     
     

Three Months Ended

 

Nine Months Ended

 
  (In thousands, except per share data)   October 4, 2020   September 29, 2019   October 4, 2020   September 29, 2019  
                     
                     
  Revenue  

$

964,025

 

 

$

706,923

 

 

$

2,428,139

 

 

$

2,078,177

 

 
                     
  Cost of revenue  

 

436,580

 

 

 

364,648

 

 

 

1,145,327

 

 

 

1,080,303

 

 
  Selling, general and administrative expenses  

 

225,249

 

 

 

204,171

 

 

 

654,844

 

 

 

604,581

 

 
  Research and development expenses  

 

50,131

 

 

 

45,376

 

 

 

148,566

 

 

 

141,700

 

 
  Restructuring and other, net  

 

4,059

 

 

 

14,068

 

 

 

11,075

 

 

 

27,868

 

 
                     
  Operating income from continuing operations  

 

248,006

 

 

 

78,660

 

 

 

468,327

 

 

 

223,725

 

 
                     
  Interest income  

 

(205

)

 

 

(292

)

 

 

(662

)

 

 

(925

)

 
  Interest expense  

 

12,057

 

 

 

16,149

 

 

 

37,308

 

 

 

49,206

 

 
  Loss on disposition of businesses and assets, net  

 

-

 

 

 

-

 

 

 

-

 

 

 

2,469

 

 
  Debt extinguishment costs  

 

-

 

 

 

471

 

 

 

-

 

 

 

471

 

 
  Other expense (income), net  

 

2,397

 

 

 

(922

)

 

 

(1,592

)

 

 

658

 

 
                     
  Income from continuing operations, before income taxes  

 

233,757

 

 

 

63,254

 

 

 

433,273

 

 

 

171,846

 

 
                     
  Provision for income taxes  

 

57,021

 

 

 

4,644

 

 

 

85,609

 

 

 

8,642

 

 
                     
  Income from continuing operations  

 

176,736

 

 

 

58,610

 

 

 

347,664

 

 

 

163,204

 

 
                     
  Loss on disposition of discontinued operations, before income taxes  

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 
  Provision for income taxes on discontinued operations and dispositions  

 

37

 

 

 

52

 

 

 

138

 

 

 

147

 

 
                     
  Loss from discontinued operations and dispositions  

 

(37

)

 

 

(52

)

 

 

(138

)

 

 

(147

)

 
                     
  Net income  

$

176,699

 

 

$

58,558

 

 

$

347,526

 

 

$

163,057

 

 
                     
                     
  Diluted earnings per share:                  
  Income from continuing operations  

$

1.57

 

 

$

0.53

 

 

$

3.11

 

 

$

1.46

 

 
                     
  Loss from discontinued operations and dispositions  

 

(0.00

)

 

 

(0.00

)

 

 

(0.00

)

 

 

(0.00

)

 
                     
  Net income  

$

1.57

 

 

$

0.52

 

 

$

3.10

 

 

$

1.46

 

 
                     
                     
  Weighted average diluted shares of common stock outstanding  

 

112,292

 

 

 

111,559

 

 

 

111,935

 

 

 

111,460

 

 
                     
                     
  ABOVE PREPARED IN ACCORDANCE WITH GAAP  
                     
                     
  Additional Supplemental Information (1):                  
  (per share, continuing operations)                  
                     
  GAAP EPS from continuing operations  

$

1.57

 

 

$

0.53

 

 

$

3.11

 

 

$

1.46

 

 
  Amortization of intangible assets  

 

0.44

 

 

 

0.37

 

 

 

1.28

 

 

 

1.09

 

 
  Debt extinguishment costs  

 

-

 

 

 

0.00

 

 

 

-

 

 

 

0.00

 

 
  Purchase accounting adjustments  

 

0.03

 

 

 

0.08

 

 

 

(0.06

)

 

 

0.16

 

 
  Acquisition and divestiture-related costs  

 

0.00

 

 

 

0.01

 

 

 

0.07

 

 

 

0.05

 

 
  Change in fair value of financial securities  

 

(0.00

)

 

 

-

 

 

 

(0.00

)

 

 

-

 

 
  Acceleration of executive compensation  

 

-

 

 

 

0.07

 

 

 

-

 

 

 

0.07

 

 
  Significant litigation matters and settlements  

 

-

 

 

 

0.01

 

 

 

0.03

 

 

 

0.01

 

 
  Significant environmental matters  

 

-

 

 

 

-

 

 

 

0.05

 

 

 

-

 

 
  Disposition of businesses and assets, net  

 

-

 

 

 

-

 

 

 

-

 

 

 

0.02

 

 
  Restructuring and other, net  

 

0.04

 

 

 

0.13

 

 

 

0.10

 

 

 

0.25

 

 
  Tax on above items  

 

(0.12

)

 

 

(0.16

)

 

 

(0.37

)

 

 

(0.40

)

 
  Impact of tax act  

 

-

 

 

 

0.02

 

 

 

-

 

 

 

0.02

 

 
  Significant tax items  

 

0.14

 

 

 

-

 

 

 

0.14

 

 

 

-

 

 
  Adjusted EPS  

$

2.09

 

 

$

1.06

 

 

$

4.33

 

 

$

2.75

 

 
                     
  (1) amounts may not sum due to rounding                  
                     
 
PerkinElmer, Inc. and Subsidiaries
REVENUE AND OPERATING INCOME (LOSS)
             
                       
                       
        Three Months Ended     Nine Months Ended
(In thousands, except percentages)   October 4, 2020     September 29, 2019     October 4, 2020     September 29, 2019
                           
                           
DAS   Reported revenue $

423,623

 

  $

426,904

 

  $

1,213,020

 

  $

1,249,704

 

                           
    Reported operating income from continued operations  

42,689

 

   

52,347

 

   

110,632

 

   

146,963

 

    OP%  

10.1

%

   

12.3

%

   

9.1

%

   

11.8

%

    Amortization of intangible assets  

17,607

 

   

13,723

 

   

58,823

 

   

37,105

 

    Purchase accounting adjustments  

-

 

   

7,429

 

   

(11,334

)

   

12,480

 

    Acquisition and divestiture-related costs  

212

 

   

444

 

   

7,045

 

   

1,403

 

    Significant litigation matters and settlements  

-

 

   

805

 

   

2,399

 

   

1,620

 

    Restructuring and other, net  

1,979

 

   

11,427

 

   

6,733

 

   

22,427

 

    Adjusted operating income  

62,487

 

   

86,175

 

   

174,298

 

   

221,998

 

    Adjusted OP%  

14.8

%

   

20.2

%

   

14.4

%

   

17.8

%

                           
Diagnostics   Reported revenue  

540,402

 

   

280,019

 

   

1,215,119

 

   

828,473

 

    Purchase accounting adjustments  

196

 

   

192

 

   

588

 

   

576

 

    Adjusted Revenue  

540,598

 

   

280,211

 

   

1,215,707

 

   

829,049

 

                           
    Reported operating income from continued operations  

223,819

 

   

47,443

 

   

413,710

 

   

128,184

 

    OP%  

41.4

%

   

16.9

%

   

34.0

%

   

15.5

%

    Amortization of intangible assets  

31,292

 

   

27,547

 

   

84,043

 

   

84,094

 

    Purchase accounting adjustments  

3,107

 

   

1,694

 

   

4,872

 

   

5,781

 

    Acquisition and divestiture-related costs  

18

 

   

393

 

   

323

 

   

1,878

 

    Significant litigation matters and settlements  

-

 

   

-

 

   

1,245

 

   

-

 

    Restructuring and other, net  

2,080

 

   

2,641

 

   

4,342

 

   

5,441

 

    Adjusted operating income  

260,316

 

   

79,718

 

   

508,535

 

   

225,378

 

    Adjusted OP%  

48.2

%

   

28.4

%

   

41.8

%

   

27.2

%

                           
Corporate   Reported operating loss  

(18,502

)

   

(21,130

)

   

(56,015

)

   

(51,422

)

    Significant environmental matters  

-

 

   

-

 

   

5,242

 

   

-

 

    Acceleration of executive compensation  

-

 

   

7,721

 

   

-

 

   

7,721

 

    Adjusted operating loss  

(18,502

)

   

(13,409

)

   

(50,773

)

   

(43,701

)

                           
Continuing Operations Reported revenue $

964,025

 

  $

706,923

 

  $

2,428,139

 

  $

2,078,177

 

    Purchase accounting adjustments  

196

 

   

192

 

   

588

 

   

576

 

    Adjusted Revenue  

964,221

 

   

707,115

 

   

2,428,727

 

   

2,078,753

 

                           
    Reported operating income from continued operations  

248,006

 

   

78,660

 

   

468,327

 

   

223,725

 

    OP%  

25.7

%

   

11.1

%

   

19.3

%

   

10.8

%

    Amortization of intangible assets  

48,899

 

   

41,270

 

   

142,866

 

   

121,199

 

    Purchase accounting adjustments  

3,107

 

   

9,123

 

   

(6,462

)

   

18,261

 

    Acquisition and divestiture-related costs  

230

 

   

837

 

   

7,368

 

   

3,281

 

    Acceleration of executive compensation  

-

 

   

7,721

 

   

-

 

   

7,721

 

    Significant litigation matters and settlements  

-

 

   

805

 

   

3,644

 

   

1,620

 

    Significant environmental matters  

-

 

   

-

 

   

5,242

 

   

-

 

    Restructuring and other, net  

4,059

 

   

14,068

 

   

11,075

 

   

27,868

 

    Adjusted operating income $

304,301

 

  $

152,484

 

  $

632,060

 

  $

403,675

 

    Adjusted OP%  

31.6

%

   

21.6

%

   

26.0

%

   

19.4

%

                           
                           
REPORTED REVENUE AND REPORTED OPERATING INCOME (LOSS) PREPARED IN ACCORDANCE WITH GAAP
 
PerkinElmer, Inc. and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEETS
   
   
       
(In thousands) October 4, 2020   December 29, 2019
       
Current assets:      
Cash and cash equivalents

$

258,293

 

 

$

191,877

 

Accounts receivable, net

 

797,911

 

 

 

725,184

 

Inventories, net

 

486,555

 

 

 

356,937

 

Other current assets

 

133,062

 

 

 

100,381

 

Total current assets

 

1,675,821

 

 

 

1,374,379

 

       
Property, plant and equipment:      
At cost

 

762,661

 

 

 

701,580

 

Accumulated depreciation

 

(426,219

)

 

 

(383,357

)

Property, plant and equipment, net

 

336,442

 

 

 

318,223

 

       
Operating lease right-of-use assets

 

193,897

 

 

 

167,276

 

Intangible assets, net

 

1,181,754

 

 

 

1,283,286

 

Goodwill

 

3,161,998

 

 

 

3,111,227

 

Other assets, net

 

315,653

 

 

 

284,173

 

Total assets

$

6,865,565

 

 

$

6,538,564

 

       
Current liabilities:      
Current portion of long-term debt

$

360,217

 

 

$

9,974

 

Accounts payable

 

258,038

 

 

 

235,855

 

Short-term accrued restructuring and other

 

10,344

 

 

 

11,559

 

Accrued expenses and other current liabilities

 

614,101

 

 

 

503,332

 

Current liabilities of discontinued operations

 

2,097

 

 

 

2,112

 

Total current liabilities

 

1,244,797

 

 

 

762,832

 

       
Long-term debt

 

1,492,633

 

 

 

2,064,041

 

Long-term liabilities

 

720,800

 

 

 

751,468

 

Operating lease liabilities

 

175,654

 

 

 

146,399

 

Total liabilities

 

3,633,884

 

 

 

3,724,740

 

       
Total stockholders' equity

 

3,231,681

 

 

 

2,813,824

 

Total liabilities and stockholders' equity

$

6,865,565

 

 

$

6,538,564

 

       
       
PREPARED IN ACCORDANCE WITH GAAP
 
PerkinElmer, Inc. and Subsidiaries
CONSOLIDATED STATEMENTS OF CASH FLOWS
         
               
  Three Months Ended   Nine Months Ended
  October 4, 2020   September 29, 2019   October 4, 2020   September 29, 2019
  (In thousands)   (In thousands)
               
Operating activities:              
Net income

$

176,699

 

 

$

58,558

 

 

$

347,526

 

 

$

163,057

 

Loss from discontinued operations and dispositions, net of income taxes

 

37

 

 

 

52

 

 

 

138

 

 

 

147

 

Income from continuing operations

 

176,736

 

 

 

58,610

 

 

 

347,664

 

 

 

163,204

 

Adjustments to reconcile income from continuing operations to net cash provided by continuing operations:              
Stock-based compensation

 

7,117

 

 

 

12,304

 

 

 

19,770

 

 

 

25,105

 

Restructuring and other, net

 

4,059

 

 

 

14,068

 

 

 

11,075

 

 

 

27,868

 

Depreciation and amortization

 

62,474

 

 

 

53,324

 

 

 

182,521

 

 

 

157,117

 

Change in fair value of contingent consideration

 

2,639

 

 

 

1,238

 

 

 

(8,807

)

 

 

4,399

 

Amortization of deferred debt financing costs and accretion of discounts

 

917

 

 

 

988

 

 

 

2,559

 

 

 

2,778

 

Loss on disposition of businesses and assets, net

 

401

 

 

 

-

 

 

 

886

 

 

 

2,469

 

Debt extinguishment costs

 

-

 

 

 

471

 

 

 

-

 

 

 

471

 

Amortization of acquired inventory revaluation

 

272

 

 

 

7,693

 

 

 

1,757

 

 

 

13,258

 

Changes in assets and liabilities which provided (used) cash, excluding effects from companies acquired:              
Accounts receivable, net

 

(72,007

)

 

 

(12,528

)

 

 

(67,695

)

 

 

(22,132

)

Inventories

 

5,773

 

 

 

2,082

 

 

 

(120,934

)

 

 

(48,367

)

Accounts payable

 

(4,517

)

 

 

5,908

 

 

 

16,391

 

 

 

(34,043

)

Accrued expenses and other

 

27,569

 

 

 

(37,443

)

 

 

24,893

 

 

 

(143,869

)

Net cash provided by operating activities of continuing operations

 

211,433

 

 

 

106,715

 

 

 

410,080

 

 

 

148,258

 

Net cash used in operating activities of discontinued operations

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net cash provided by operating activities

 

211,433

 

 

 

106,715

 

 

 

410,080

 

 

 

148,258

 

               
Investing activities:              
Capital expenditures

 

(20,253

)

 

 

(16,621

)

 

 

(57,391

)

 

 

(53,082

)

Purchases of investments

 

(2,166

)

 

 

(4,519

)

 

 

(9,559

)

 

 

(5,387

)

Purchases of licenses

 

-

 

 

 

-

 

 

 

-

 

 

 

(5,000

)

Proceeds from surrender of life insurance policies

 

-

 

 

 

-

 

 

 

131

 

 

 

-

 

Proceeds from disposition of businesses and assets

 

608

 

 

 

-

 

 

 

2,423

 

 

 

550

 

Payment of acquisitions, net of cash and cash equivalents acquired

 

(712

)

 

 

(7,882

)

 

 

(3,702

)

 

 

(252,620

)

Net cash used in investing activities of continuing operations

 

(22,523

)

 

 

(29,022

)

 

 

(68,098

)

 

 

(315,539

)

Net cash provided by investing activities of discontinued operations

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net cash used in investing activities

 

(22,523

)

 

 

(29,022

)

 

 

(68,098

)

 

 

(315,539

)

               
Financing Activities:              
Payments on borrowings

 

(225,210

)

 

 

(841,489

)

 

 

(515,210

)

 

 

(1,419,489

)

Proceeds from borrowings

 

69,000

 

 

 

184,866

 

 

 

257,000

 

 

 

1,034,416

 

Proceeds from sale of senior debt

 

-

 

 

 

847,195

 

 

 

-

 

 

 

847,195

 

Payments of debt financing costs

 

-

 

 

 

(7,741

)

 

 

-

 

 

 

(7,922

)

Settlement of cash flow hedges

 

(7,126

)

 

 

72

 

 

 

(2,089

)

 

 

(1,587

)

Net payments on other credit facilities

 

(2,088

)

 

 

(1,360

)

 

 

(8,124

)

 

 

(11,166

)

Payments for acquisition-related contingent consideration

 

-

 

 

 

(4,500

)

 

 

(5,200

)

 

 

(28,200

)

Proceeds from issuance of common stock under stock plans

 

17,454

 

 

 

1,009

 

 

 

27,528

 

 

 

17,563

 

Purchases of common stock

 

(159

)

 

 

(144

)

 

 

(6,829

)

 

 

(6,201

)

Dividends paid

 

(7,809

)

 

 

(7,775

)

 

 

(23,381

)

 

 

(23,282

)

Net cash (used in) provided by financing activities of continuing operations

 

(155,938

)

 

 

170,133

 

 

 

(276,305

)

 

 

401,327

 

Net cash used in financing activities of discontinued operations

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net cash (used in) provided by financing activities

 

(155,938

)

 

 

170,133

 

 

 

(276,305

)

 

 

401,327

 

               
Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

5,490

 

 

 

(5,069

)

 

 

832

 

 

 

(4,384

)

               
Net increase in cash, cash equivalents, and restricted cash

 

38,462

 

 

 

242,757

 

 

 

66,509

 

 

 

229,662

 

Cash, cash equivalents, and restricted cash at beginning of period

 

219,941

 

 

 

153,220

 

 

 

191,894

 

 

 

166,315

 

Cash, cash equivalents, and restricted cash at end of period

$

258,403

 

 

$

395,977

 

 

$

258,403

 

 

$

395,977

 

               
               
Supplemental disclosure of cash flow information:              
Reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total shown in the consolidated statements of cash flows:              
Cash and cash equivalents

$

258,293

 

 

$

392,969

 

 

$

258,293

 

 

$

392,969

 

Restricted cash included in other current assets

 

110

 

 

 

3,008

 

 

 

110

 

 

 

3,008

 

Total cash, cash equivalents and restricted cash

$

258,403

 

 

$

395,977

 

 

$

258,403

 

 

$

395,977

 

               
PREPARED IN ACCORDANCE WITH GAAP
 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
             
(In millions, except per share data and percentages)   PKI  
   

Three Months Ended

 
    October 4, 2020   September 29, 2019    
             
Adjusted revenue:            
Revenue  

$

964.0

 

 

$

706.9

 

   
Purchase accounting adjustments  

 

0.2

 

 

 

0.2

 

   
Adjusted revenue  

$

964.2

 

 

$

707.1

 

   
             
Adjusted gross margin:            
Gross margin  

$

527.4

 

54.7

%

$

342.3

 

48.4

%

 
Amortization of intangible assets  

 

16.7

 

1.7

%

 

15.2

 

2.1

%

 
Purchase accounting adjustments  

 

0.5

 

0.0

%

 

7.9

 

1.1

%

 
Adjusted gross margin  

$

544.6

 

56.5

%

$

365.3

 

51.7

%

 
         
Adjusted SG&A:            
SG&A  

$

225.2

 

23.4

%

$

204.2

 

28.9

%

 
Amortization of intangible assets  

 

(32.2

)

-3.3

%

 

(26.1

)

-3.7

%

 
Purchase accounting adjustments  

 

(2.6

)

-0.3

%

 

(1.2

)

-0.2

%

 
Acquisition and divestiture-related expenses  

 

(0.2

)

0.0

%

 

(0.8

)

-0.1

%

 
Acceleration of executive compensation  

 

-

 

0.0

%

 

(7.7

)

-1.1

%

 
Significant litigation matters and settlements  

 

-

 

0.0

%

 

(0.8

)

-0.1

%

 
Significant environmental matters  

 

-

 

0.0

%

 

-

 

0.0

%

 
Adjusted SG&A  

$

190.2

 

19.7

%

$

167.5

 

23.7

%

 
             
Adjusted R&D:            
R&D  

$

50.1

 

5.2

%

$

45.4

 

6.4

%

 
Adjusted R&D  

$

50.1

 

5.2

%

$

45.4

 

6.4

%

 
             
Adjusted operating income:            
Operating income  

$

248.0

 

25.7

%

$

78.7

 

11.1

%

 
Amortization of intangible assets  

 

48.9

 

5.1

%

 

41.3

 

5.8

%

 
Purchase accounting adjustments  

 

3.1

 

0.3

%

 

9.1

 

1.3

%

 
Acquisition and divestiture-related expenses  

 

0.2

 

0.0

%

 

0.8

 

0.1

%

 
Acceleration of executive compensation  

 

-

 

0.0

%

 

7.7

 

1.1

%

 
Significant litigation matters and settlements  

 

-

 

0.0

%

 

0.8

 

0.1

%

 
Significant environmental matters  

 

-

 

0.0

%

 

-

 

0.0

%

 
Restructuring and other, net  

 

4.1

 

0.4

%

 

14.1

 

2.0

%

 
Adjusted operating income  

$

304.3

 

31.6

%

$

152.5

 

21.6

%

 
             
    PKI  
   

Three Months Ended

 
    October 4, 2020   September 29, 2019    
             
Adjusted EPS:            
GAAP EPS  

$

1.57

 

 

$

0.52

 

   
Discontinued operations, net of income taxes  

 

(0.00

)

 

 

(0.00

)

   
GAAP EPS from continuing operations  

 

1.57

 

 

 

0.53

 

   
Amortization of intangible assets  

 

0.44

 

 

 

0.37

 

   
Debt extinguishment costs  

 

-

 

 

 

0.00

 

   
Purchase accounting adjustments  

 

0.03

 

 

 

0.08

 

   
Acquisition and divestiture-related expenses  

 

0.00

 

 

 

0.01

 

   
Change in fair value of financial securities  

 

(0.00

)

 

 

-

 

   
Acceleration of executive compensation  

 

-

 

 

 

0.07

 

   
Significant litigation matters and settlements  

 

-

 

 

 

0.01

 

   
Restructuring and other, net  

 

0.04

 

 

 

0.13

 

   
Tax on above items  

 

(0.12

)

 

 

(0.16

)

   
Impact of tax act  

 

-

 

 

 

0.02

 

   
Significant tax items  

 

0.14

 

 

 

-

 

   
Adjusted EPS  

$

2.09

 

 

$

1.06

 

   
             
    DAS  
   

Three Months Ended

 
    October 4, 2020   September 29, 2019    
             
Revenue  

$

423.6

 

 

$

426.9

 

   
             
Adjusted operating income:            
Operating income  

$

42.7

 

10.1

%

$

52.3

 

12.3

%

 
Amortization of intangible assets  

 

17.6

 

4.2

%

 

13.7

 

3.2

%

 
Purchase accounting adjustments  

 

-

 

0.0

%

 

7.4

 

1.7

%

 
Acquisition and divestiture-related expenses  

 

0.2

 

0.1

%

 

0.4

 

0.1

%

 
Significant litigation matters and settlements  

 

-

 

0.0

%

 

0.8

 

0.2

%

 
Restructuring and other, net  

 

2.0

 

0.5

%

 

11.4

 

2.7

%

 
Adjusted operating income  

$

62.5

 

14.8

%

$

86.2

 

20.2

%

 
             
    Diagnostics  
   

Three Months Ended

 
    October 4, 2020   September 29, 2019    
             
Adjusted revenue:            
Revenue  

$

540.4

 

 

$

280.0

 

   
Purchase accounting adjustments  

 

0.2

 

 

 

0.2

 

   
Adjusted revenue  

$

540.6

 

 

$

280.2

 

   
             
Adjusted operating income:            
Operating income  

$

223.8

 

41.4

%

$

47.4

 

16.9

%

 
Amortization of intangible assets  

 

31.3

 

5.8

%

 

27.5

 

9.8

%

 
Purchase accounting adjustments  

 

3.1

 

0.6

%

 

1.7

 

0.6

%

 
Acquisition and divestiture-related expenses  

 

0.0

 

0.0

%

 

0.4

 

0.1

%

 
Significant litigation matters and settlements  

 

-

 

0.0

%

 

-

 

0.0

%

 
Restructuring and other, net  

 

2.1

 

0.4

%

 

2.6

 

0.9

%

 
Adjusted operating income  

$

260.3

 

48.2

%

$

79.7

 

28.4

%

 
             
             
(1) amounts may not sum due to rounding            
 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
             
(In millions, except per share data and percentages)   PKI  
   

Nine Months Ended

 
   

October 4, 2020

 

September 29, 2019

   
             
Adjusted revenue:            
Revenue  

$

2,428.1

 

 

$

2,078.2

 

   
Purchase accounting adjustments  

 

0.6

 

 

 

0.6

 

   
Adjusted revenue  

$

2,428.7

 

 

$

2,078.8

 

   
             
Adjusted gross margin:            
Gross margin  

$

1,282.8

 

52.8

%

$

997.9

 

48.0

%

 
Amortization of intangible assets  

 

48.8

 

2.0

%

 

45.6

 

2.2

%

 
Purchase accounting adjustments  

 

2.3

 

0.1

%

 

13.8

 

0.7

%

 
Adjusted gross margin  

$

1,333.9

 

54.9

%

$

1,057.3

 

50.9

%

 
         
Adjusted SG&A:            
SG&A  

$

654.8

 

27.0

%

$

604.6

 

29.1

%

 
Amortization of intangible assets  

 

(94.1

)

-3.9

%

 

(75.6

)

-3.6

%

 
Purchase accounting adjustments  

 

8.8

 

0.4

%

 

(4.4

)

-0.2

%

 
Acquisition and divestiture-related expenses  

 

(7.4

)

-0.3

%

 

(3.3

)

-0.2

%

 
Acceleration of executive compensation  

 

-

 

0.0

%

 

(7.7

)

-0.4

%

 
Significant litigation matters and settlements  

 

(3.6

)

-0.2

%

 

(1.6

)

-0.1

%

 
Significant environmental matters  

 

(5.2

)

-0.2

%

 

-

 

0.0

%

 
Adjusted SG&A  

$

553.3

 

22.8

%

$

512.0

 

24.6

%

 
             
Adjusted R&D:            
R&D  

$

148.6

 

6.1

%

$

141.7

 

6.8

%

 
Adjusted R&D  

$

148.6

 

6.1

%

$

141.7

 

6.8

%

 
             
Adjusted operating income:            
Operating income  

$

468.3

 

19.3

%

$

223.7

 

10.8

%

 
Amortization of intangible assets  

 

142.9

 

5.9

%

 

121.2

 

5.8

%

 
Purchase accounting adjustments  

 

(6.5

)

-0.3

%

 

18.3

 

0.9

%

 
Acquisition and divestiture-related expenses  

 

7.4

 

0.3

%

 

3.3

 

0.2

%

 
Acceleration of executive compensation  

 

-

 

0.0

%

 

7.7

 

0.4

%

 
Significant litigation matters and settlements  

 

3.6

 

0.2

%

 

1.6

 

0.1

%

 
Significant environmental matters  

 

5.2

 

0.2

%

 

-

 

0.0

%

 
Restructuring and other, net  

 

11.1

 

0.5

%

 

27.9

 

1.3

%

 
Adjusted operating income  

$

632.1

 

26.0

%

$

403.7

 

19.4

%

 
             
    PKI  
   

Nine Months Ended

 
    October 4, 2020   September 29, 2019    
             
Adjusted EPS:            
GAAP EPS  

$

3.10

 

 

$

1.46

 

   
Discontinued operations  

 

(0.00

)

 

 

(0.00

)

   
GAAP EPS from continuing operations  

 

3.11

 

 

 

1.46

 

   
Amortization of intangible assets  

 

1.28

 

 

 

1.09

 

   
Debt extinguishment costs  

 

-

 

 

 

0.00

 

   
Purchase accounting adjustments  

 

(0.06

)

 

 

0.16

 

   
Significant litigation matters and settlements  

 

0.03

 

 

 

0.01

 

   
Significant environmental matters  

 

0.05

 

 

 

-

 

   
Acquisition and divestiture-related expenses  

 

0.07

 

 

 

0.05

 

   
Change in fair value of financial securities  

 

(0.00

)

 

 

-

 

   
Acceleration of executive compensation  

 

-

 

 

 

0.07

 

   
Loss (gain) on disposition of businesses and assets, net  

 

-

 

 

 

0.02

 

   
Restructuring and other, net  

 

0.10

 

 

 

0.25

 

   
Tax on above items  

 

(0.37

)

 

 

(0.40

)

   
Impact of tax act  

 

-

 

 

 

0.02

 

   
Significant tax items  

 

0.14

 

 

 

-

 

   
Adjusted EPS  

$

4.33

 

 

$

2.75

 

   
             
    PKI  
        Three Months Ended    
        January 3, 2021    
Adjusted EPS:       Projected    
GAAP EPS from continuing operations       $2.27 - $2.67    
Amortization of intangible assets      

 

0.43

 

   
Purchase accounting adjustments      

 

0.01

 

   
Acquisition and divestiture-related expenses      

 

0.00

 

   
Tax on above items      

 

(0.11

)

   
Adjusted EPS       $2.60 - $3.00    
             
    DAS  
   

Nine Months Ended

 
    October 4, 2020   September 29, 2019    
             
Revenue  

$

1,213.0

 

 

$

1,249.7

 

   
             
Adjusted operating income:            
Operating income  

$

110.6

 

9.1

%

$

147.0

 

11.8

%

 
Amortization of intangible assets  

 

58.8

 

4.8

%

 

37.1

 

3.0

%

 
Purchase accounting adjustments  

 

(11.3

)

-0.9

%

 

12.5

 

1.0

%

 
Acquisition and divestiture-related expenses  

 

7.0

 

0.6

%

 

1.4

 

0.1

%

 
Significant litigation matters and settlements  

 

2.4

 

0.2

%

 

1.6

 

0.1

%

 
Restructuring and other, net  

 

6.7

 

0.6

%

 

22.4

 

1.8

%

 
Adjusted operating income  

$

174.3

 

14.4

%

$

222.0

 

17.8

%

 
             
    Diagnostics  
   

Nine Months Ended

 
    October 4, 2020   September 29, 2019    
             
Adjusted revenue:            
Revenue  

$

1,215.1

 

 

$

828.5

 

   
Purchase accounting adjustments  

 

0.6

 

 

 

0.6

 

   
Adjusted revenue  

$

1,215.7

 

 

$

829.0

 

   
             
Adjusted operating income:            
Operating income  

$

413.7

 

34.0

%

$

128.2

 

15.5

%

 
Amortization of intangible assets  

 

84.0

 

6.9

%

 

84.1

 

10.2

%

 
Purchase accounting adjustments  

 

4.9

 

0.4

%

 

5.8

 

0.7

%

 
Acquisition and divestiture-related expenses  

 

0.3

 

0.0

%

 

1.9

 

0.2

%

 
Significant litigation matters and settlements  

 

1.2

 

0.1

%

 

-

 

0.0

%

 
Restructuring and other, net  

 

4.3

 

0.4

%

 

5.4

 

0.7

%

 
Adjusted operating income  

$

508.5

 

41.8

%

$

225.4

 

27.2

%

 
             
             
(1) amounts may not sum due to rounding            
 
PerkinElmer, Inc. and Subsidiaries
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (1)
           
           
    PKI  
      Three Months Ended    
      October 4, 2020    
Organic revenue growth:          
Reported revenue growth    

36%

   
Less: effect of foreign exchange rates    

1%

   
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses    

1%

   
Organic revenue growth    

34%

   
           
           
    DAS  
      Three Months Ended    
      October 4, 2020    
Organic revenue growth:          
Reported revenue growth    

-1%

   
Less: effect of foreign exchange rates    

1%

   
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses    

1%

   
Organic revenue growth    

-3%

   
           
           
    Diagnostics  
      Three Months Ended    
      October 4, 2020    
Organic revenue growth:          
Reported revenue growth    

93%

   
Less: effect of foreign exchange rates    

1%

   
Less: effect of acquisitions including purchase accounting adjustments and impact of divested businesses    

0%

   
Organic revenue growth    

92%

   
           
(1) amounts may not sum due to rounding          
 

Explanation of Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, management believes that, in order to more fully understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash, non-recurring or other items, which result from facts and circumstances that vary in frequency and impact on continuing operations. Accordingly, we present non-GAAP financial measures as a supplement to the financial measures we present in accordance with GAAP. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by adjusting for certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management's ability to make useful forecasts. Management believes these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

We use the term “adjusted revenue” to refer to GAAP revenue, including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We use the related term “adjusted revenue growth” to refer to the measure of comparing current period adjusted revenue with the corresponding period of the prior year.

We use the term “organic revenue” to refer to GAAP revenue, excluding the effect of foreign currency changes and including acquisitions growth from the comparable prior period, and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules. We also exclude the impact of sales from divested businesses by deducting the effects of divested business revenue from the current and prior periods. We use the related term “organic revenue growth” to refer to the measure of comparing current period organic revenue with the corresponding period of the prior year.

We use the term “adjusted gross margin” to refer to GAAP gross margin, excluding amortization of intangible assets and inventory fair value adjustments related to business acquisitions, and including purchase accounting adjustments for revenue from contracts acquired in acquisitions that will not be fully recognized due to business combination accounting rules. We use the related term “adjusted gross margin percentage” to refer to adjusted gross margin as a percentage of adjusted revenue.

We use the term “adjusted SG&A expense” to refer to GAAP SG&A expense, excluding amortization of intangible assets, purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters and settlements, and significant environmental charges. We use the related term “adjusted SG&A percentage” to refer to adjusted SG&A expense as a percentage of adjusted revenue.

We use the term “adjusted R&D expense” to refer to GAAP R&D expense, excluding amortization of intangible assets and purchase accounting adjustments. We use the related term “adjusted R&D percentage” to refer to adjusted R&D expense as a percentage of adjusted revenue.

We use the term “adjusted net interest and other expense” to refer to GAAP net interest and other expense, excluding adjustments for mark-to-market accounting on post-retirement benefits, changes in the value of financial securities and debt extinguishment costs.

We use the term “adjusted operating income,” to refer to GAAP operating income, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding amortization of intangible assets, other purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters and settlements, significant environmental charges, and restructuring and other charges. We use the related terms “adjusted operating profit percentage,” “adjusted operating profit margin,” or “adjusted operating margin” to refer to adjusted operating income as a percentage of adjusted revenue.

We use the term “adjusted earnings per share,” or “adjusted EPS,” to refer to GAAP earnings per share, including revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules, and excluding discontinued operations, amortization of intangible assets, debt extinguishment costs, other purchase accounting adjustments, acquisition and divestiture-related expenses, acceleration of executive compensation, significant litigation matters and settlments, significant environmental charges, changes in the value of financial securities, disposition of businesses and assets, net, and restructuring and other charges. We also exclude adjustments for mark-to-market accounting on post-retirement benefits, therefore only our projected costs have been used to calculate this non-GAAP measure. We also adjust for any tax impact related to the above items and exclude the impact of significant tax events.

 

Management includes or excludes the effect of each of the items identified below in the applicable non-GAAP financial measure referenced above for the reasons set forth below with respect to that item:

  • Amortization of intangible assets— purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
  • Debt extinguishment costs—we incur costs and income related to the extinguishment of debt; including make-whole payments to debt holders, accelerated amortization of debt fees and discounts, and expense or income from hedges to lock in make whole payments. We exclude the impact of these items from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Revenue from contracts acquired in acquisitions that will not be fully recognized due to accounting rules—accounting rules require us to account for the fair value of revenue from contracts assumed in connection with our acquisitions. As a result, our GAAP results reflect the fair value of those revenues, which is not the same as the revenue that otherwise would have been recorded by the acquired entity. We include such revenue in our non-GAAP measures because we believe the fair value of such revenue does notaccurately reflect the performance of our ongoing operations for the period in which such revenue is recorded.
  • Other purchase accounting adjustments—accounting rules require us to adjust various balance sheet accounts, including inventory and deferred rent balances to fair value at the time of the acquisition. As a result, the expenses for these items in our GAAP results are not the same as what would have been recorded by the acquired entity. Accounting rules also require us to estimate the fair value of contingent consideration at the time of the acquisition, and any subsequent changes to the estimate or payment of the contingent consideration and purchase accounting adjustments are charged to expense or income. We exclude the impact of any changes to contingent consideration from our non-GAAP measures because we believe these expenses or benefits do notaccurately reflect the performance of our ongoing operations for the period in which such expenses or benefits are recorded.
  • Acquisition and divestiture-related expenses—we incur legal, due diligence, stay bonuses, incentive awards, interest expense, foreign exchange gains and losses, significant acquisition integration expenses and other costs related to acquisitions and divestitures. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Acceleration of executive compensationthe announced retirement of a senior executive resulted in an acceleration of compensation expense. We exclude these expenses from our non-GAAP measures because we believe they do not reflect the performance of our ongoing operations.
  • Restructuring and other charges—restructuring and other charges consist of employee severance, other exit costs as well as the cost of terminating certain lease agreements or contracts as well as costs associated with relocating facilities. Management does not believe such costs accurately reflect the performance of our ongoing operations for the period in which such costs are reported.
  • Adjustments for mark-to-market accounting on post-retirement benefits—we exclude adjustments for mark-to-market accounting on post-retirement benefits, and therefore only our projected costs are used to calculate our non-GAAP measures. We exclude these adjustments because they do not represent what we believe our investors consider to be costs of producing our products, investments in technology and production, and costs to support our internal operating structure.
  • Significant litigation matters and settlements—we incur expenses related to significant litigation matters, including the costs to settle or resolve various claims and legal proceedings. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Significant environmental charges—we incur expenses related to significant environmental charges. Management does not believe such charges accurately reflect the performance of our ongoing operations for the periods in which such charges were incurred.
  • Disposition of businesses and assets, net—we exclude the impact of gains or losses from the disposition of businesses and assets from our adjusted earnings per share. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported.
  • Impact of foreign currency changes on the current period—we exclude the impact of foreign currency from these measures by using the prior period’s foreign currency exchange rates for the current period because foreign currency exchange rates are subject to volatility and can obscure underlying trends.
  • Impact of significant tax events – we exclude the impact of significant tax audits, assessments and events, such as the Tax Cuts and Jobs Act of 2017. Management does not believe the impact of significant tax audits, assessments and events accurately reflects the performance of our ongoing operations for the periods in which the impact of such events were recorded.
  • Changes in value of financial securities—we exclude the impact of changes in the value of financial securities. Management does not believe such gains or losses accurately reflect the performance of our ongoing operations for the period in which such gains or losses are reported.
 

The tax effect for discontinued operations is calculated based on the authoritative guidance in the Financial Accounting Standards Board’s Accounting Standards Codification 740, Income Taxes. The tax effect for amortization of intangible assets, inventory fair value adjustments related to business acquisitions, changes to the fair values assigned to contingent consideration, debt extinguishment costs, other costs related to business acquisitions and divestitures, acceleration of executive compensation, significant litigation matters and settlements, significant environmental charges, changes in the fair value of financial securities, adjustments for mark-to-market accounting on post-retirement benefits, disposition of businesses and assets, net, restructuring and other charges, and the revenue from contracts acquired with various acquisitions is calculated based on operational results and applicable jurisdictional law, which contemplates tax rates currently in effect to determine our tax provision. The tax effect for the impact from foreign currency exchange rates on the current period is calculated based on the average rate currently in effect to determine our tax provision.

The non-GAAP financial measures described above are not meant to be considered superior to, or a substitute for, our financial statements prepared in accordance with GAAP. There are material limitations associated with non-GAAP financial measures because they exclude charges that have an effect on our reported results and, therefore, should not be relied upon as the sole financial measures by which to evaluate our financial results. Management compensates and believes that investors should compensate for these limitations by viewing the non-GAAP financial measures in conjunction with the GAAP financial measures. In addition, the non-GAAP financial measures included in this earnings announcement may be different from, and therefore may not be comparable to, similar measures used by other companies.

Each of the non-GAAP financial measures listed above is also used by our management to evaluate our operating performance, communicate our financial results to our Board of Directors, benchmark our results against our historical performance and the performance of our peers, evaluate investment opportunities including acquisitions and discontinued operations, and determine the bonus payments for senior management and employees.

Investor Relations:
PerkinElmer, Inc.
Bryan Kipp (781) 663-5583
bryan.kipp@perkinelmer.com

Media:
PerkinElmer, Inc.
Fara Goldberg (781) 663-5699
fara.goldberg@perkinelmer.com

Source: PerkinElmer, Inc.

Related Links

IR Contact

ir@perkinelmer.com
(781) 663 - 6900
940 Winter Street
Waltham, MA 02451
United States
www.perkinelmer.com

Transfer Agent

Mailing addresses
Correspondence should be mailed to:
Computershare
P.O. Box 505000
Louisville, KY 40233

Overnight correspondence should be sent to:
Computershare
462 South 4th Street, Suite 1600
Louisville, KY 40202

Shareholder website www.computershare.com/investor
Shareholder online inquiries
www-us.computershare.com/investor/Contact